1. Background
2. Objectives
3. Methods
3.1. Statistical Analysis
4. Results
| Variables/Groups | Pretest | Posttest | P-Value |
|---|---|---|---|
| Age (y) | |||
| SP-GT | 25.4 ± 3.5 | - | - |
| SP-PL | 24.8 ± 3.7 | - | - |
| Control | 24.3 ± 3.8 | - | - |
| Body Weight (kg) | |||
| SP-GT | 70.5 ± 7.8 | 67.5 ± 7.4c | 0.001c |
| SP-PL | 69.7 ± 4.7 | 67.7 ± 4.4c | 0.001c |
| Control | 69.5 ± 5.9 | 69.8 ± 6 | 0.06 |
| Height (cm) | |||
| SP-GT | 162.2 ± 4.7 | - | - |
| SP-PL | 161.9 ± 3.8 | - | - |
| Control | 162.1 ± 4.5 | - | - |
| BMI (kg/m2) | |||
| SP-GT | 26.7 ± 1.7 | 25.5 ± 1.7c | 0.001c |
| SP-PL | 26.8 ± 1.4 | 26.06 ± 1.4c | 0.001c |
| Control | 26.4 ± 1.4 | 26.5 ± 1.4 | 0.07 |
| Energy (kcal/day) | |||
| SP-GT | 1907 ± 17.6 | 1898 ± 19.1 | 0.66 |
| SP-PL | 1916 ± 28.4 | 1912 ± 24.8 | 0.57 |
| Control | 1918 ± 12.3 | 1920 ± 16.7 | 0.39 |
| Protein (g/day) | |||
| SP-GT | 57.5 ± 2.9 | 57.7 ± 2.05 | 0.66 |
| SP-PL | 59.1 ± 1.2 | 58.7 ± 1.01 | 0.17 |
| Control | 57.1 ± 1.4 | 56.6 ± 1.4 | 0.37 |
| Fat (g/day) | |||
| SP-GT | 59.02 ± 0.62 | 59.03 ± 0.63 | 0.99 |
| SP-PL | 58.7 ± 0.51 | 58.6 ± 0.75 | 0.87 |
| Control | 58.5 ± 1 | 58.8 ± 0.94 | 0.06 |
| Carbohydrate (g/day) | |||
| SP-GT | 286.4 ± 1.9 | 284.2 ± 8.3 | 0.38 |
| SP-PL | 287.8 ± 2.6 | 287.5 ± 2.9 | 0.88 |
| Control | 290.7 ± 2.1 | 291 ± 2.5 | 0.87 |
Abbreviations: BMI, body mass index; SP-GT, spinning-green tea; SP-PL, spinning-placebo.
a Values are expressed as mean ± SD unless otherwise indicated.
b Significant difference at P ≤ 0.05.
c Significant difference with pretest.
| Variables/Groups | Pretesta | Posttesta | Repeated Measures ANOVA | Pretest-Posttest | Differences | ||
|---|---|---|---|---|---|---|---|
| Source | F | p | |||||
| TNF-α (ng/l) | |||||||
| SP-GT | 289.14 ± 164 | 194.4 ± 88.9 | Time | 8.2 | 0.008 | SP-GT | 0.012b |
| SP-PL | 307.7 ± 92.1 | 292.1 ± 92.4 | Group | 7.2 | 0.003 | SP-PL | 0.001b |
| Control | 422.4 ± 106.9 | 432.2 ± 96.6 | Time × Group | 7.3 | 0.003 | Control | 0.191 |
| IL-6 (ng/l) | |||||||
| SP-GT | 235.19 ± 105.6 | 225.24 ± 96.09 | Time | 0.078 | 0.783 | SP-GT | 0.182 |
| SP-PL | 283.69 ± 86.08 | 280.82 ± 84.4 | Group | 4.38 | 0.022 | SP-PL | 0.24 |
| Control | 329.23 ± 44.8 | 349.67 ± 47 | Time × Group | 15.97 | 0.001 | Control | 0.011b |
| IL-10 (ng/ml) | |||||||
| SP-GT | 55.4 ± 18.4 | 64 ± 18.8 | Time | 25 | 0.001 | SP-GT | 0.001b |
| SP-PL | 59.4 ± 17.3 | 61.6 ± 16.07 | Group | 1.85 | 0.177 | SP-PL | 0.104 |
| Control | 46.7 ± 13.7 | 47.3 ± 12.8 | Time × Group | 10.48 | 0.001 | Control | 0.722 |
| BMI (kg/m2) | |||||||
| SP-GT | 26.7 ± 1.7 | 25.5 ± 1.7 | Time | 157.6 | 0.001 | SP-GT | 0.001b |
| SP-PL | 26.8 ± 1.4 | 26.06 ± 1.4 | Group | 4.7 | 0.018 | SP-PL | 0.001b |
| Control | 26.4 ± 1.4 | 26.5 ± 1.4 | Time × Group | 69.6 | 0.001 | Control | 0.074 |
| BF (%) | |||||||
| SP-GT | 34.6 ± 4.5 | 31.2 ± 3.6 | Time | 108.3 | 0.001 | SP-GT | 0.001b |
| SP-PL | 36.7 ± 4.2 | 35.3 ± 3.9 | Group | 4.65 | 0.018 | SP-PL | 0.001b |
| Control | 38.7 ± 2.6 | 38.2 ± 2.7 | Time × Group | 46.4 | 0.001 | Control | 0.27 |
Abbreviations: TNF-α, tumor necrosis-alpha; IL-6, interleukin-6; IL-10, interleukine-10; BF, body fat.
a Values are presented as mean ± SD.
bSignificant difference with pretest.
| Variables/Groups | Intergroup Difference | |
|---|---|---|
| Pretest | Posttest | |
| TNF-α (ng/l) | ||
| (SP-GT)-(SP-PL) | 0.73 | 0.21 |
| (SP-GT)-control | 0.03a | 0.001a |
| (SP-PL)-control | 0.06 | 0.016a |
| IL-6 (ng/l) | ||
| (SP-GT)-(SP-PL) | 0.19 | 0.12 |
| (SP-GT)-control | 0.058 | 0.007a |
| (SP-PL)-control | 0.26 | 0.152 |
| IL-10 (ng/ml) | ||
| (SP-GT)-(SP-PL) | 0.58 | 0.91 |
| (SP-GT)-control | 0.27 | 0.11 |
| (SP-PL)-control | 0.11 | 0.09 |
| BMI (kg/m2) | ||
| (SP-GT)-(SP-PL) | 0.85 | 0.609 |
| (SP-GT)-control | 0.06 | 0.007a |
| (SP-PL)-control | 0.08 | 0.021a |
| BF (%) | ||
| (SP-GT)-(SP-PL) | 0.22 | 0.62 |
| (SP-GT)-control | 0.07 | 0.006a |
| (SP-PL)-control | 0.48 | 0.243 |
a Significant difference at P ≤ 0.05.